Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV
V Minard-Colin, Y Xiu, JC Poe… - Blood, The Journal …, 2008 - ashpublications.org
Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV
V Minard-Colin, Y Xiu, JC Poe, M Horikawa, CM Magro… - Blood, 2008 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Despite the demonstrated clinical efficacy of
CD20 monoclonal antibody (mAb) for lymphoma therapy, the in vivo mechanisms of tumor …
CD20 monoclonal antibody (mAb) for lymphoma therapy, the in vivo mechanisms of tumor …
Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.
V Minard-Colin, Y Xiu, JC Poe, M Horikawa, CM Magro… - Blood, 2008 - europepmc.org
Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
[PDF][PDF] Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcRI, FcRIII, and FcRIV
V Minard-Colin, Y Xiu, JC Poe, M Horikawa, CM Magro… - BLOOD, 2008 - Citeseer
Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
[引用][C] Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage Fcγ/RI, FcγRΙΙΙ, and FcγRIV
V MINARD-COLIN, YAN XIU, JC POE, M HORIKAWA… - Blood, 2008 - pascal-francis.inist.fr
Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage Fcγ/RI,
FcγRΙΙΙ, and FcγRIV CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
FcγRΙΙΙ, and FcγRIV CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[HTML][HTML] Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV
V Minard-Colin, Y Xiu, JC Poe, M Horikawa, CM Magro… - Blood, 2008 - Elsevier
Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
[PDF][PDF] Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcRI, FcRIII, and FcRIV
V Minard-Colin, Y Xiu, JC Poe, M Horikawa, CM Magro… - BLOOD, 2008 - researchgate.net
Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV
V Minard-Colin, Y Xiu, JC Poe, M Horikawa… - …, 2008 - pubmed.ncbi.nlm.nih.gov
Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
[HTML][HTML] Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV
V Minard-Colin, Y Xiu, JC Poe, M Horikawa, CM Magro… - Blood, 2008 - ncbi.nlm.nih.gov
Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and …
[引用][C] Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV
V MINARD-COLIN - Blood, 2008 - cir.nii.ac.jp
Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI,
FcγRIII, and FcγRIV | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
FcγRIII, and FcγRIV | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …